|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400092015 |
|
最近更新日期: Date of Last Refreshed on: |
2024-11-07 15:06:05 |
|
注册时间: Date of Registration: |
2024-11-07 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
基于中国母乳研究的新一代婴配乳粉制造技术研究及示范 |
|
Public title: |
Research and Demonstration of a New Generation of Infant Formula Manufacturing Technology Based on Chinese Breast Milk Research |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于中国母乳研究的新一代婴配乳粉制造技术研究及示范 |
|
Scientific title: |
Research and Demonstration of a New Generation of Infant Formula Manufacturing Technology Based on Chinese Breast Milk Research |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
闫媛媛 |
研究负责人: |
王慧 |
|
Applicant: |
Yuanyuan Yan |
Study leader: |
Hui Wang |
|
申请注册联系人电话: Applicant telephone: |
+86 183 2197 0015 |
研究负责人电话: Study leader's telephone: |
+86 21 6384 6590 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
yanyuanyuan0801@outlook.com |
研究负责人电子邮件: Study leader's E-mail: |
huiwang@shsmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市黄浦区重庆南路227号 |
研究负责人通讯地址: |
上海市黄浦区重庆南路227号 |
|
Applicant address: |
227 Chongqing South Road, Huangpu District, Shanghai, China |
Study leader's address: |
227 Chongqing South Road, Huangpu District, Shanghai, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海交通大学 |
||
|
Applicant's institution: |
Shanghai Jiao Tong University |
||
|
研究负责人所在单位: |
上海交通大学 |
||
|
Affiliation of the Leader: |
Shanghai Jiao Tong University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
SJUPN-202304 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海交通大学医学院公共卫生及护理科研伦理委员会 |
||
|
Name of the ethic committee: |
Public Health and Nursing Research Ethics Committee of Shanghai Jiaotong University School of Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-04-24 00:00:00 |
||
|
伦理委员会联系人: |
王慧 |
||
|
Contact Name of the ethic committee: |
Hui Wang |
||
|
伦理委员会联系地址: |
上海市黄浦区重庆南路227号 |
||
|
Contact Address of the ethic committee: |
227 Chongqing South Road, Huangpu District, Shanghai, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 6384 6590 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海交通大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Jiao Tong University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市黄浦区重庆南路227号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
227 Chongqing South Road, Huangpu District, Shanghai, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中央财政专项资金、其他来源资金 |
||||||||||||||||||||||
|
Source(s) of funding: |
Specialized funds from the central government, funds from other sources |
||||||||||||||||||||||
|
Target disease: |
N/A |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
针对我国母乳功能组分变化规律不清、检测与功能评价方法不完善、婴配粉制造技术不能满足中国婴幼儿营养需求的问题,项目将突破我国母乳研究瓶颈,解析我国母乳组分变化规律和结构特征,攻克保活、节能、提升可湿性的婴配粉工艺,建设中国母乳样本库及组分数据共享平台,创新检测、功能评价和制造关键技术,研制基于中国母乳研究数据、营养活性得到有效保持的新一代婴配粉,并对其喂养效果进行全面系统的评价,实现产业化示范。项目的实施将为设计满足中国婴幼儿营养需求的婴配粉提供科学依据,提升国产婴配粉市场占有率,促进我国婴配行业健康发展 |
||||||||||||||||||||||
|
Objectives of Study: |
Aiming at the problems of unclear change rules of functional components of Chinese breast milk, imperfect testing and functional evaluation methods, and the manufacturing technology of infant formula not being able to meet the nutritional needs of Chinese infants and young children, the project will break through the bottleneck of China's breast milk research, analyze the change rules of components of China's breast milk and its structural characteristics, overcome the process of infant formula that preserves the activity, conserves energy, and improves the wettability, build a database of China's breast milk samples and a platform for sharing data on the components, and innovate the testing and functional evaluation and manufacturing key technologies, Functional evaluation and manufacturing key technologies, to develop a new generation of baby powder based on China's breast milk research data, effectively maintain the nutritional activity, and conduct a comprehensive and systematic evaluation of its feeding effect, and realize industrialization demonstration. The implementation of the project will provide scientific basis for the design of infant formula that meets the nutritional needs of Chinese infants and young children, enhance the market share of domestic infant formula, and promote the healthy development of China's infant formula industry. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
临床诊断健康且不影响母乳喂养的产妇: (1)孕周:37~41+6周; (2)年龄:20~40周岁; (3)母亲健康状况:无母乳喂养禁忌症; (4)母乳喂养意愿强烈; (5)产后体检、儿保召回生产医院进行诊断; (6)能熟练使用智能手机; (7)受试者或监护人签署知情同意书; (8)受试者承诺整个研究期间配合研究,愿意依据采样规范完成样本采集,填写健康与膳食调查问卷。 |
||||||||||||||||||||||
|
Inclusion criteria |
Mothers who are clinically diagnosed as healthy and do not interfere with breastfeeding: (1) Week of pregnancy: 37~41+6 weeks; (2) Age: 20~40 weeks; (3) Health of the mother: no contraindications to breastfeeding; (4) Strong desire to breastfeed; (5) Postnatal physical examination, pediatric recall of the birth hospital for diagnosis; (6) Skilled in the use of smart phones; (7) The subject or guardian signed an informed consent form; (8) Subjects committed to cooperate with the study throughout the study period, willing to complete the sample collection according to the sampling specifications, fill out the health and dietary questionnaires. |
||||||||||||||||||||||
|
排除标准: |
有下列情况者不入选: (1)在孕期发生严重营养性或遗传性疾病、严重妊娠合并症和并发症、内分泌疾病等影响母乳喂养者; (2)生产后不在本院进行产后体检和儿保; (3)受试者依从性较差,随访可能性差。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Those with the following conditions will not be selected: (1) Those with severe nutritional or hereditary diseases, serious pregnancy complications and complications, and endocrine diseases that interfere with breastfeeding during pregnancy; (2) Not undergoing postnatal physical examination and pediatric care at our hospital after delivery; (3) Subjects with poor compliance and poor likelihood of follow-up. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-10-01 00:00:00至 To 2027-01-10 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2023-11-27 00:00:00 至 To 2025-04-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
项目任务书中注明了,数据至少保密三年 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The project task book specifies that the data must be kept confidential for at least three years |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture, EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |